China
GL Ventures leads $130m round for China’s Biren
Biren Technology, a Chinese artificial intelligence (AI) chip design company, has raised a RMB900 million ($130 million) pre-Series B round led by GL Ventures, the VC unit of Hillhouse Capital.
Xiaomi-backed Soocas raises $25m pre-IPO round
Soocas, a Shenzhen-based electric toothbrush maker backed by smart phone maker Xiaomi has raised a RMB175 million ($25 million) pre-IPO round led by Grand Flight Investment Management.
Hillhouse invests $830m in China’s JD Health
Hillhouse Capital has agreed to invest $830 million in JD Health, the healthcare unit of Chinese e-commerce giant JD.com, which will remain the majority shareholder.
China children's English education platform raises $120m
Chinese children's English education platform Palfish, also known as Banyu, has raised a $120 million Series C round led by Tao Zhang, founder of Dianping.com, and FutureX Capital.
Lever VC reaches $23m first close on food fund
Lever VC, a Hong Kong and US-based food tech specialist, has confirmed a $23 million first close for its debut fund, which will invest alternative protein start-ups globally with a strong focus on China.
Centurium buys Beijing children's hospital
Centurium Capital has acquired a controlling stake in Beijing Jingdu Children’s Hospital, which claims to be the largest privately-owned children’s hospital in China, for approximately $150 million.
China medical device player Hanyu Medical secures $72m
China-based medical devices manufacturer Hanyu Medical has raised a RMB500 million ($72 million) Series D co-led by HighLight Capital, CPE (formerly known as CITIC Private Equity), and Yingke Private Equity.
China’s JD.com acquires VC-backed logistics player
Chinese e-commerce giant JD.com has agreed to pay RMB3 billion ($432 million) for a controlling stake in Kuayue Express, a local VC-backed logistics operator.
China’s VC-backed CanSino raises $748m in Star Market IPO
Chinese vaccine developer CanSino Biologics, which counts Lily Asia Ventures (LAV) and Qiming Venture Partners among its investors, has raised RMB5.2 billion ($748 million) in an IPO on Shanghai’s Star Market.
China's Vision Medicals raises $28m
CDH Investment has led a RMB200 million ($28 million) Series B round for Guangzhou-based precision diagnosis and gene sequencing company Vision Medicals.
Yunfeng backs take-private of China-US biotech player
Yunfeng Capital, a private equity firm co-founded by Jack Ma, is backing the privatization of Cellular Biomedicine, a US and China-based biotech developer.
Tencent plots merger of China live-streaming platforms
Tencent Holdings has proposed a merger of Douyu and Huya – China’s two largest game-centric live-streaming platforms. Both NASDAQ-listed companies have a number of VC investors.
Start-up profiles: Sustainability agendas
Early-stage innovators across the region are leveraging both enterprise and consumer-facing models to address sustainability challenges with one eye on rapid commercialization
ByteDance acquires Chinese medical platform for $72m
ByteDance, the PE-backed owner of TikTok and the Toutiao news aggregation service, has acquired VC-backed Chinese medical information platform Baikemy for RMB500 million ($72 million).
Chinese CRO player Yaoyanshe raises $86m
Yaoyanshe, a Chinese contract research organization (CRO) for novel drugs, has raised RMB600 million ($86 million) across two rounds in the past eight months.
China clean energy: Policy power
China’s aggressive renewable energy development targets are creating opportunities for investors in various points along the supply chain, but inconsistent regulation remains a concern
Chinese EV manufacturer Xpeng pursues US IPO
Xpeng Motors, a Chinese electric vehicle (EV) manufacturer backed by Alibaba Group and several PE and VC firms, has filed for a US IPO.
Chinese chip design company Brite raises $50m
Chinese integrated circuit (IC) design company Brite Semiconductor, has raised a RMB350 million ($50 million) Series D round led by Haitong Securities and sector specialist Sunic Capital.
PAI Capital invests $212m in Chinese video display business
PAI Capital, a Hong Kong and London-based asset manager that primarily caters to high net worth individuals (HNWIs), has paid RMB1.45 billion ($212 million) for a 24.22% stake in Vtron Group, a Shenzhen-listed video display systems manufacturer.
Huagai leads $43m round for China antibiotics developer
China-focused private equity firm Huagai Capital has a led a RMB300 million ($43 million) Series D round for antibiotics developer MicuRX Pharmaceuticals.
Tencent leads $360m round for China fresh produce retailer
Chinese fresh produce retailer Yipin Shengxian has raised a RMB2.5 billion ($360 million) Series C round led by Tencent Holdings and Capital Today. Eastern Bell Venture Capital re-upped.
GPs & climate change risk: Material matters
Climate change risk is becoming a broader debate within private equity, taking in the long-term impact of floods, droughts, and fires on portfolios. Most GPs have yet to turn thought into action
Legend leads $20m Series B for China's Exegenesis Bio
Chinese gene therapy specialist Exegenesis Bio has received $20 million in Series B funding led by Legend Capital. It will be used to support clinical development of the company’s drug portfolio.
Chinese EV maker Xpeng raises another $300m
Alibaba Group has led a $300 million round for Chinese electric vehicle (EV) manufacturer Xpeng Motors. It comes barely two weeks after the company closed an extended Series C round of $500 million.